logo
  • Home
  • News
Menu

GC Pharma Announces GreenGene F Approval in China for the Treatment of Haemophilia A

Home / Stock Analysis / GC Pharma Announces GreenGene F Approval in China for the Treatment of Haemophilia A
Article feature image

GC Pharma Announces GreenGene F Approval in China for the Treatment of Haemophilia A

12 Aug Stock Analysis

YONGIN, South Korea–(BUSINESS WIRE)–GC Pharma (006280.KS) today announced the approval of GreenGene F (Beroctocog alfa)

Click here to view the original article.

Tags:
Business Wire, Global
Facebook Google+ Twitter Pinterest
  Previous
Next  

Related Posts

maruti-suzuki-share-price-today-live-03-dec-2025.jpg
+

Maruti Suzuki Share Price Live Updates: Maruti Suzuki’s Market Activity Overview

03 Dec Stock Analysis
AUSmallFinanceB_technicaldot_3742966.png
+

AU Small Finance Bank Shows Mixed Technical Signals Amid Strong Price Momentum

03 Dec Stock Analysis

recent post

  • maruti-suzuki-share-price-today-live-03-dec-2025.jpg

    Maruti Suzuki Share Price Live Updates:

    Dec 03 2025
  • blockheadco_strengthening_bitcoin._composite_image_colorful_mag_cfd6cf00-9b30-4ca8-8585-af5409445047.webp

    Bitcoin Rebounds Above $92,000 as Bank

    Dec 03 2025
  • AUSmallFinanceB_technicaldot_3742966.png

    AU Small Finance Bank Shows Mixed

    Dec 03 2025
  • shutterstock_193757372-5bfc46594cedfd0026c73587.jpg

    10 Canadian Marijuana Stocks for Your

    Dec 03 2025
  • 2a85b209e6a3f3bad2d1b0c5ac41f732.jpeg

    ‘Trump Accounts’ offering free $1,000 per

    Dec 03 2025

Categories

  • Business
  • Crypto News
  • Investing Strategy
  • People
  • Stock Analysis

©2019.  All Rights Reserved.